Atrás
26
Rango del Día
$75.40
$78.04
Rango de 52 Semanas
$47.25
$108.91
Volumen
746,303
Promedio 50D / 200D
$71.57
/
$65.11
Cierre Anterior
$76.43
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 21.5 | 0.4 |
| P/B | 4.6 | 2.9 |
| ROE % | 21.5 | 3.8 |
| Net Margin % | 15.2 | 3.9 |
| Rev Growth 5Y % | 38.0 | 10.0 |
| D/E | 0.0 | 0.2 |
Puntos Clave
Revenue grew 37.99% annually over 5 years — strong growth
Earnings declined -25.25% over the past year
ROE of 21.45% indicates high profitability
Net margin of 15.15% shows strong profitability
Debt/Equity of 0.00 — conservative balance sheet
Generating 354.05M in free cash flow
Crecimiento
Revenue Growth (5Y)
37.99%
Revenue (1Y)0.50%
Earnings (1Y)-25.25%
FCF Growth (3Y)16.99%
Calidad
Return on Equity
21.45%
ROIC21.38%
Net Margin15.15%
Op. Margin20.16%
Seguridad
Debt / Equity
0.00
Current Ratio2.70
Interest Coverage15.74
Valoración
P/E Ratio
21.50
P/B Ratio4.61
EV/EBITDA15.00
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0.50% | Revenue Growth (3Y) | 9.05% |
| Earnings Growth (1Y) | -25.25% | Earnings Growth (3Y) | -15.44% |
| Revenue Growth (5Y) | 37.99% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.54B | Net Income (TTM) | 233.56M |
| ROE | 21.45% | ROA | 10.49% |
| Gross Margin | 61.10% | Operating Margin | 20.16% |
| Net Margin | 15.15% | Free Cash Flow (TTM) | 354.05M |
| ROIC | 21.38% | FCF Growth (3Y) | 16.99% |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 2.70 |
| Interest Coverage | 15.74 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 21.50 | P/B Ratio | 4.61 |
| P/S Ratio | 3.26 | PEG Ratio | -0.82 |
| EV/EBITDA | 15.00 | Dividend Yield | 0.00% |
| Market Cap | 5.02B | Enterprise Value | 4.66B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.54B | 1.53B | 1.30B | 935.06M | 425.21M |
| Net Income | 233.56M | 312.44M | 326.66M | 28.07M | -71.28M |
| EPS (Diluted) | 3.41 | 4.36 | 4.65 | 0.40 | -1.06 |
| Gross Profit | 941.95M | 988.29M | 709.54M | 581.70M | 187.70M |
| Operating Income | 310.83M | 456.98M | 364.64M | 36.20M | -60.83M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.23B | 1.98B | 1.65B | 1.32B | 863.78M |
| Total Liabilities | 1.14B | 892.33M | 835.26M | 874.11M | 399.35M |
| Shareholders' Equity | 1.09B | 1.09B | 815.89M | 447.15M | 464.44M |
| Total Debt | 738,000.0 | 619.44M | 616.95M | 583.51M | 191.31M |
| Cash & Equivalents | 359.12M | 912.81M | 713.66M | 415.65M | 98.51M |
| Current Assets | 899.96M | 1.33B | 1.09B | 677.62M | 235.79M |
| Current Liabilities | 333.42M | 240.53M | 187.35M | 247.70M | 90.50M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#171 of 195
Actividad Reciente
Entró
Value Investing (Warren Buffett)
Mar 24, 2026